Sight Sciences (SGHT) Competitors $3.57 +0.21 (+6.25%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SGHT vs. IRMD, AXGN, SMLR, SIBN, KIDS, TMCI, CLPT, NNOX, TCMD, and DCTHShould you be buying Sight Sciences stock or one of its competitors? The main competitors of Sight Sciences include Iradimed (IRMD), AxoGen (AXGN), Semler Scientific (SMLR), SI-BONE (SIBN), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Nano-X Imaging (NNOX), Tactile Systems Technology (TCMD), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Sight Sciences vs. Iradimed AxoGen Semler Scientific SI-BONE OrthoPediatrics Treace Medical Concepts ClearPoint Neuro Nano-X Imaging Tactile Systems Technology Delcath Systems Iradimed (NASDAQ:IRMD) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership. Does the MarketBeat Community prefer IRMD or SGHT? Iradimed received 235 more outperform votes than Sight Sciences when rated by MarketBeat users. Likewise, 64.78% of users gave Iradimed an outperform vote while only 29.82% of users gave Sight Sciences an outperform vote. CompanyUnderperformOutperformIradimedOutperform Votes25264.78% Underperform Votes13735.22% Sight SciencesOutperform Votes1729.82% Underperform Votes4070.18% Do analysts recommend IRMD or SGHT? Iradimed currently has a consensus target price of $60.00, indicating a potential upside of 9.79%. Sight Sciences has a consensus target price of $5.12, indicating a potential upside of 43.42%. Given Sight Sciences' higher probable upside, analysts clearly believe Sight Sciences is more favorable than Iradimed.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iradimed 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.17 Is IRMD or SGHT more profitable? Iradimed has a net margin of 26.12% compared to Sight Sciences' net margin of -63.30%. Iradimed's return on equity of 23.99% beat Sight Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Iradimed26.12% 23.99% 20.45% Sight Sciences -63.30%-47.28%-32.72% Which has more risk & volatility, IRMD or SGHT? Iradimed has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500. Comparatively, Sight Sciences has a beta of 2.58, meaning that its share price is 158% more volatile than the S&P 500. Does the media refer more to IRMD or SGHT? In the previous week, Iradimed and Iradimed both had 2 articles in the media. Iradimed's average media sentiment score of 0.77 beat Sight Sciences' score of 0.40 indicating that Iradimed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iradimed 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sight Sciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in IRMD or SGHT? 92.3% of Iradimed shares are held by institutional investors. Comparatively, 55.5% of Sight Sciences shares are held by institutional investors. 37.1% of Iradimed shares are held by insiders. Comparatively, 28.9% of Sight Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has better earnings and valuation, IRMD or SGHT? Iradimed has higher earnings, but lower revenue than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIradimed$71.31M9.71$17.19M$1.4637.43Sight Sciences$79.54M2.28-$55.55M-$1.02-3.50 SummaryIradimed beats Sight Sciences on 14 of the 17 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGHT vs. The Competition Export to ExcelMetricSight SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$181.20M$4.34B$5.12B$9.07BDividend YieldN/A41.46%4.91%4.22%P/E Ratio-3.5025.3791.3417.19Price / Sales2.2845.961,117.70116.80Price / CashN/A43.4542.6437.86Price / Book1.457.364.794.78Net Income-$55.55M$13.64M$120.07M$225.60M7 Day Performance-0.28%-2.80%-1.90%-1.23%1 Month Performance-5.05%0.56%11.45%3.37%1 Year Performance13.33%41.87%30.63%16.58% Sight Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGHTSight Sciences3.3924 of 5 stars$3.57+6.3%$5.12+43.4%+7.2%$181.20M$79.54M-3.50210News CoverageHigh Trading VolumeIRMDIradimed4.3866 of 5 stars$53.24+1.2%$60.00+12.7%+20.2%$674.55M$65.56M36.05110Positive NewsAXGNAxoGen0.9827 of 5 stars$14.56+2.8%$15.00+3.0%+125.0%$640.76M$180.86M-44.47426Positive NewsSMLRSemler Scientific1.301 of 5 stars$73.98+10.1%N/A+44.1%$613.29M$68.18M35.2792Gap DownHigh Trading VolumeSIBNSI-BONE4.3112 of 5 stars$13.89+3.5%$23.00+65.6%-35.2%$582.55M$138.89M-14.59350Positive NewsKIDSOrthoPediatrics3.8714 of 5 stars$22.49+1.7%$40.00+77.9%-29.8%$544.71M$148.73M-17.98200Analyst ForecastTMCITreace Medical Concepts1.7006 of 5 stars$7.59+1.2%$7.40-2.5%-36.6%$472.86M$187.12M-7.58250Analyst ForecastNews CoverageCLPTClearPoint Neuro0.45 of 5 stars$16.37+6.8%$11.33-30.8%+142.2%$451.57M$30.43M-22.21110Positive NewsNNOXNano-X Imaging2.3594 of 5 stars$7.48+8.6%$12.00+60.4%+2.9%$432.19M$10.68M-8.79190Positive NewsTCMDTactile Systems Technology3.5784 of 5 stars$17.85-0.4%$23.00+28.9%+23.9%$428.40M$274.42M27.57980Analyst UpgradeDCTHDelcath Systems2.8196 of 5 stars$12.56+3.7%$21.50+71.2%+212.8%$401.59M$22.64M-9.6776Gap DownHigh Trading Volume Related Companies and Tools Related Companies IRMD Alternatives AXGN Alternatives SMLR Alternatives SIBN Alternatives KIDS Alternatives TMCI Alternatives CLPT Alternatives NNOX Alternatives TCMD Alternatives DCTH Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SGHT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sight Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sight Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGHT Stock Alerts